Reactive Hypoglycemia (After Meals): Symptoms and How to Tell If It Is Really That

When glucose falls below the level the brain needs to function, a cascade of defensive reactions is triggered. The first line is adrenergic (autonomic) symptoms, resulting from a surge of adrenaline: shaky hands, sweating, a racing heart, a feeling of anxiety, pallor, ravenous hunger and tingling around the mouth. If glucose falls further, neuroglycopenic symptoms are added, resulting from a shortage of glucose in the brain: difficulty concentrating, confusion, visual disturbances, headache, weakness, drowsiness, speech disturbance and, in severe cases, loss of consciousness or seizures.

The problem is that adrenergic symptoms are not specific to hypoglycemia. Identical shakiness, palpitations and anxiety are produced by anxiety itself, panic attacks, excess caffeine, an overactive thyroid, dehydration, heart rhythm disorders, postural tachycardia syndrome, some medications, and even the stress reaction to the fear of low blood sugar. That is why a reliable diagnosis requires linking symptoms to a specific glucose measurement, not to the mere feeling of 'I think my sugar is too low'.

That leaves the question of the glucose level at which we call it hypoglycemia. There is no single, universal value for people without diabetes: the clinical literature most often uses thresholds around 54–60 mg/dl (3.0–3.3 mmol/l); in studies of hypoglycemia after bariatric surgery, for example, a threshold below 54 mg/dl is used, and Brun et al. point to a threshold of 3.3 mmol/l (about 60 mg/dl) for diagnosing postprandial hypoglycemia. That value must, however, be measured at the time of symptoms, in a laboratory or well-calibrated measurement, and not inferred from sensations.

The Endocrine Society guideline on hypoglycemia in adults (Cryer et al., 2009) recommends evaluating and managing hypoglycemia only in people in whom Whipple's triad has been documented: symptoms or signs consistent with hypoglycemia, a low plasma glucose, and resolution of symptoms after glucose is raised. This requirement follows from a simple fact: nonspecific symptoms are common, and a low glucose reading without symptoms (for example in a test or a sensor) does not have to be clinically meaningful. Only the convergence of all three elements allows us to assume that the problem really is low blood sugar.

A review published in Endocrine Practice (Palani et al., 2023) emphasizes that spontaneous hypoglycemia is uncommon in people who are not taking glucose-lowering medication, because under physiological conditions numerous neural and hormonal mechanisms prevent glucose from falling to dangerously low values. If hypoglycemia is nevertheless suspected, laboratory tests should be done during a spontaneous symptomatic episode and, if necessary, supplemented with controlled tests, such as a 72-hour fast or a mixed-meal test, which recreate the situation that triggers symptoms.

In many clinics and online descriptions, there is a belief that reactive hypoglycemia can be detected with an 'extended glucose tolerance test' (even 4–5 hours long). The available data indicate that this approach leads to misdiagnoses. After drinking a large dose of plain glucose, in many perfectly healthy people glucose falls after a few hours to values below the normal fasting range, and this does not have to cause any complaints.

The review by Brun et al. (2000) reaches a similar conclusion: neither the glucose tolerance test nor a mixed meal is suitable for this diagnosis, owing respectively to false-positive and false-negative results, and they should be replaced by ambulatory glycemic monitoring or a proposed carbohydrate-rich breakfast test. A 2023 review (Palani et al.), in contrast, lists the mixed meal as one of the supervised tests that may be needed when episodes cannot be captured spontaneously. Views on which test is best therefore differ depending on context, and all sources agree on one thing: a fall in glucose in a test alone, without correspondence to symptoms, is not enough.

The popularization of CGM sensors among people without diabetes has meant that many see for the first time that their glucose over the day is not a straight line, and some of them interpret every dip below 70 mg/dl as proof of reactive hypoglycemia. Yet a multicenter reference study in 153 healthy people without diabetes (Shah et al., 2019) showed that the median time below 70 mg/dl was 1.1% of the day, i.e. about 15 minutes a day, with mean glucose around 98–99 mg/dl. Short episodes below 70 mg/dl are therefore present in healthy people, without any symptoms, and are not in themselves hypoglycemia in the clinical sense.

On top of this come technical limitations. CGM sensors measure glucose in interstitial fluid, so their readings lag behind blood and carry their own error, most apparent in the low range. A known artefact is false 'nocturnal lows' after pressure on the sensor during sleep. A low value from a sensor, especially a single nocturnal one, is therefore worth verifying with a fingerstick. We write about the broader limitations of CGM in healthy people in a separate article on continuous glucose monitoring.

An interesting example of how much the picture depends on the tool is studies in people after bariatric surgery. In the study by Ramos-Levi et al. (2023), which used a mixed-meal test and CGM, hypoglycemia (below 54 mg/dl) occurred in 60% of patients after the test and in 75% during CGM, and in most cases was asymptomatic. The meal test confirmed the diagnosis in 88.9% of patients who had undergone surgery more than three years earlier, and in only 36.4% with a shorter time since surgery; CGM additionally showed asymptomatic nocturnal hypoglycemia in 70% of patients. This shows both the usefulness of these tools in an appropriately selected population and the fact that low glucose does not always cause symptoms, and symptoms do not always mean low glucose.

In the meta-analysis by Lupoli et al. (2022), covering 8 studies and 280 people after bariatric surgery using CGM, the pooled frequency of postprandial hypoglycemia was 54.3% (95% CI 44.5–63.8%), and of nocturnal hypoglycemia 16.4%; the frequency after gastric bypass and after sleeve gastrectomy did not differ significantly, although bypass was associated with greater glycemic variability. This result refers only to that population and does not transfer to people without surgery. Insulinoma, a rare islet cell tumor of the pancreas, in turn, is not a typical explanation for symptoms after ordinary meals: in the typical clinical picture it produces hypoglycemia with symptoms when fasting, in the morning or after exertion, and diagnostics include measuring insulin, C-peptide, proinsulin and beta-hydroxybutyrate during an episode and, if needed, a supervised fast.

Brun et al. (2000) present hypotheses of the mechanisms of 'functional' postprandial hypoglycemia: an exaggerated insulin response related to insulin resistance or increased GLP-1 secretion, renal glycosuria, defects in the glucagon response, and high insulin sensitivity, which the authors consider the most frequent cause (50–70%). This is, however, a review based on the team's own observations rather than the result of large randomized trials, so these estimates should be treated as hypotheses. Likewise, the observation that the problem more often affects very lean people or those after major weight loss remains a hypothesis.

Dietary recommendations in confirmed postprandial hypoglycemia rest mainly on clinical experience and small studies. Brun et al. indicate that diet remains the mainstay of treatment (limiting high-glycemic-index dietary carbohydrates and alcohol), and in some patients alpha-glucosidase inhibitors can be helpful, which is a doctor's decision. After bariatric surgery, strategies include dietary modification and, in harder cases, pharmacotherapy, but discussing them is beyond the scope of this article.

Reactive hypoglycemia is one of those diagnoses that patients make for themselves more often than doctors do, and study data show that in most cases complaints after a meal are not linked to a measured low glucose. That does not mean the symptoms are 'made up' — shakiness, palpitations and fatigue are real — but that it is worth looking for their real cause rather than assuming a ready-made explanation. The most valuable tool is not an expensive test but a simple diary and one well-performed glucose measurement at the time of symptoms.